Literature DB >> 31145546

Splice variant in ARX leading to loss of C-terminal region in a boy with intellectual disability and infantile onset developmental and epileptic encephalopathy.

Cheryl Shoubridge1,2, Matilda Jackson1,2, Bronwyn Grinton3, Samuel F Berkovic3, Ingrid E Scheffer3,4, Shannon Huskins5, Alison Thomas6, Tyson Ware7.   

Abstract

Pathogenic variants in the X-chromosome Aristaless-related homeobox (ARX) gene contribute to intellectual disability, epilepsy, and associated comorbidities in affected males. Here, we report a novel splice variant in ARX in a family with three affected individuals. The proband had early onset developmental and epileptic encephalopathy, his brother and mother had severe and mild intellectual disability, respectively. Massively parallel sequencing identified a novel c.1449-1G>C in intron 4 of the ARX gene, predicted to abolish the splice acceptor site, retaining intron 4 and leading to a premature termination codon immediately after exon 4. As exon 5 is the last exon of the ARX gene, the premature termination codon at position p.L484* would be predicted to escape nonsense-mediated mRNA decay, potentially producing at least some C-terminally truncated protein. Analysis of cDNA from patient lymphoblastoid cells confirmed retention of intron 4 and loss of detectable expression of ARX mRNA across exon 4 to exon 5. We review published cases of variants that lead to altered or early termination of the ARX protein, but not complete loss of function, and are associated with phenotypes of intellectual disability and infantile onset developmental and epileptic encephalopathies, including Ohtahara and West syndromes. Taken together, this novel splice variant retaining intron 4 is likely to be the cause of the early onset developmental and epileptic encephalopathy in the proband.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  ARX; Ohtahara syndrome; epilepsy; intellectual disability; splice

Year:  2019        PMID: 31145546     DOI: 10.1002/ajmg.a.61216

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

1.  Novel ARX mutation identified in infantile spasm syndrome patient.

Authors:  Yohei Takeshita; Tatsuyuki Ohto; Takashi Enokizono; Mai Tanaka; Hisato Suzuki; Hiroko Fukushima; Tomoko Uehara; Toshiki Takenouchi; Kenjiro Kosaki; Hidetoshi Takada
Journal:  Hum Genome Var       Date:  2020-03-31

2.  CRISPR/Cas9 Genome Editing of the Human Topoisomerase IIα Intron 19 5' Splice Site Circumvents Etoposide Resistance in Human Leukemia K562 Cells.

Authors:  Victor A Hernandez; Jessika Carvajal-Moreno; Jonathan L Papa; Nicholas Shkolnikov; Junan Li; Hatice Gulcin Ozer; Jack C Yalowich; Terry S Elton
Journal:  Mol Pharmacol       Date:  2021-01-14       Impact factor: 4.436

3.  Epidemiology and etiology of infantile developmental and epileptic encephalopathies in Tasmania.

Authors:  Tyson L Ware; Shannon R Huskins; Bronwyn E Grinton; Yu-Chi Liu; Mark F Bennett; Michael Harvey; Jacinta McMahon; Danae Andreopoulos-Malikotsinas; Melanie Bahlo; Katherine B Howell; Michael S Hildebrand; John A Damiano; Alexander Rosenfeld; Mark T Mackay; Simone Mandelstam; Richard J Leventer; A Simon Harvey; Jeremy L Freeman; Ingrid E Scheffer; Dean L Jones; Samuel F Berkovic
Journal:  Epilepsia Open       Date:  2019-07-22

4.  Novel ARX mutation identified in infantile spasm syndrome patient.

Authors:  Yohei Takeshita; Tatsuyuki Ohto; Takashi Enokizono; Mai Tanaka; Hisato Suzuki; Hiroko Fukushima; Tomoko Uehara; Toshiki Takenouchi; Kenjiro Kosaki; Hidetoshi Takada
Journal:  Hum Genome Var       Date:  2020-03-31

5.  Screening of the duplication 24 pb of ARX gene in Moroccan patients with X-linked Intellectual Disability.

Authors:  Yousra Benmakhlouf; Renaud Touraine; Ines Harzallah; Zeineb Zian; Kaoutar Ben Makhlouf; Amina Barakat; Naima Ghailani Nourouti; Mohcine Bennani Mechita
Journal:  BMC Res Notes       Date:  2021-03-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.